Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2010, Vol. 30 Issue (08): 131-135    DOI: Q819
    
Current Status and Trends Analysis of Japan Bioindustry Development
YIN Jun-xiang,LI Rui-guo
China National Center for Biotechnology Development, Beijing 100036,China
Download: HTML   PDF(457KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Japan is the world leader in the biotechnology area, bioindustry is its priority of all industries, the government accelerated bioindustry through optimizing development strategies, perfecting related institutions, rising financial input and promoting the combination of government, business and research and so on. The current status of bioindustry in Japan were reviewed, and its development directions and focuses in the future on the basis of Japanese situations and advantages were analyzed, the aim is providing references for our country's bioindustry development.



Key wordsJapan      Bioindustry      Policies      Funds      Organizations      Trends     
Received: 23 July 2010      Published: 25 August 2010
Cite this article:

YIN Jun-Xiang, LI Rui-Guo. Current Status and Trends Analysis of Japan Bioindustry Development. China Biotechnology, 2010, 30(08): 131-135.

URL:

https://manu60.magtech.com.cn/biotech/Q819     OR     https://manu60.magtech.com.cn/biotech/Y2010/V30/I08/131

[1] Biotechnology Strategy Guideline. Biotechnology Strategy Council, 2002, 12. 6 
[2] 彭仁, 林晴如, 谢娟霞. 日本生物产业的发展现状及展望. 产业与科技论坛, 2008, 7(1) : 250252. 
[3] 郑风田, 辛本胜. 日本生物技术产业政策评述及启示. 科学学研究,2006, 24(增刊):486489. Zheng F T, Xin S B. Studies in Science of Science. 2006, 24(Supp): 486489. 
[4] Lehrer M, Kazuhiro Asakawa. Rethinking the public sector:idiosyncrasies of biotechnology commercialization as motors of national R&D reform in Germany and Japan. Research Policy, 2004, (33): 921938. 
[5] Government of Japan. The Science and Technology Basic Plan (2001 2005). Tokyo, 2001 
[6] 张治然,刁天喜,高云华. 日本生物医药产业发展现状与展望. 中国医药导报,2010, 7(1):141143. Zhang Z R, Diao T X, Gao Y H. China Medical Herald, 2010, 7(1):141143. 
[7] SaKai M. Technological innovation of production method of liquefied biomass fuels:themo chemical production method of methanol fuels from any types of biomass. Farming Jpn, 2001, 35(2)1015. 
[8] Martin Fransman,Shoko Tanaka. Government, globalization, and universities in Japanese biotechnology. Research Policy, 1995, 24: 1349. 
[9] 朱信凯, 涂圣伟, 杨顺江. 国际生物技术产业政策评论及对我国的启示. 中国软科学, 2005, 11: 1824. Zhu X K, Tu S W, Yang S J. China Soft Science Magazine, 2005, 11: 1824. 
[10] 孙国风. 日本5省厅生物技术产业的振兴战略. 生物技术通报, 2000, 1: 51. Gun G F.Biotechnique, 2001,1:51. 
[11] Attractive sectors, biotechnology. Japan External Trade Organization. 2007, 10 
[12] Fransman M, Shoko Tanaka. Government,globalization and universities in Japanese biotechnology .Research Policy, 1995, 24:1349. 
[13] Aldar S. Bourinbaiar. Recent developments in biotech industry outside of the USA and Western Europe: Report from BIO 2005. 2006,9 (2): 95 
[14] Implementing a national biotechnology strategy in Japan. Japan External Trade Organization. Biooutsourcing Asia,2010,3(1):3 
[15] Science: A matter of life; Novel technologies in life science from Western Japan. Japan External Trade Organization. Biooutsourcing Asia, 2010, 3 (1): 11 
[16] 杨欣, 顾和平, 陈新, 等.日本生物能源研究的进展.安徽农学通报. 2009, 15(7): 8284. Yang X, Gu H P, Chen X, et al. Anhui Agri Sci Bull, 2009, 15(7): 8284. 
[17] Christian Muller, Takao Fujiwara. The entrepreneurial environment for biotech startups in Germany and Japan . International Journal of Biotechnology, 2003 , 5(1): 7694. 
[18] Nakagawa H. Developmont and cultivation of forage grasses and crops for clean biomathanol production to kee Pglobal environment.Farming Jpn, 2001, 35 (2) 2231. 
[19] Mark Lehrer, Kazuhiro Asakawa. Rethinking the public sector: idiosyncrasies of biotechnology 17commercialization as motors of national R&D reform in Germany and Japan . Research Policy, 2004, 33: 921938.

[1] WU Han-rong,WANG Ying,YANG Li,GE Yao,FAN Ling. Current Situation and Development Suggestions of China’s Biotechnology Base Platform[J]. China Biotechnology, 2021, 41(11): 119-123.
[2] GUO Guang-chao,ZHOU Yu-yong,CAO San-jie,WU Yao-min,WU Rui,ZHAO Qin,WEN Xin-tian,HUANG Xiao-bo,WEN Yi-ping. The Study on the Effect of NS2A-C60A Site Mutation of Japanese Encephalitis Virus on Its Biological Characteristics[J]. China Biotechnology, 2020, 40(9): 1-10.
[3] Fang CHEN,Yun-wei CHEN,Chen-jun DING,Ying ZHENG,Xiao-yan WU,Dan-dan LUO,Qiu-wei ZHAO,Bo YU. A Study on the Trends of Biotechnology Development in Countries along the Belt and Road[J]. China Biotechnology, 2018, 38(1): 1-14.
[4] GUO Zhong-ping, XU Li. Revision of the General Policies of Nomenclature for Biological Products in China[J]. China Biotechnology, 2017, 37(8): 110-118.
[5] CHEN Fang, DING Chen-jun, CHEN Yun-wei, ZHENG Ying, DENG Yong, XU Ping, YU Jian-rong, WU Lin-huan, MA Jun-cai, ZENG Yan, LIU Bin. A Study on the Trend and Prospective of Industrial Biotechnology in China[J]. China Biotechnology, 2016, 36(5): 1-11.
[6] GUO Yang, LIN Hua. The New Development of Japanese Encephalitis Vaccine and Vaccine Research[J]. China Biotechnology, 2015, 35(10): 66-71.
[7] SUN Qian, XU Li, ZHOU Mao-xin, ZHONG Hui. Comparison of Patent Examination Between China and Japan Concerning Novelty and Inventiveness of Protein Products[J]. China Biotechnology, 2013, 33(12): 133-136.
[8] YIN Jun-Xiang, LI Rui-Guo. The Current Status and Trends Analysis on the Development of South Korea Bioindustry[J]. China Biotechnology, 2010, 30(08): 136-140.
[9] LI Rui-Guo, YIN Jun-Xiang, ZHANG Da-Lu. Status and Trends Analysis of Thailand Bioindustry Development[J]. China Biotechnology, 2010, 30(07): 116-120.
[10] SHU Lu, LONG Quan-Ke, LIU Hai-Feng, LU Meng-Bei, HU Yuan, DAN You-En, TU Long-Jiang. Construction and Immuno-protection Evaluation of Trivalent-epitope DNA Vaccine pVIVO2-SjFABP/Sj26.SjGAPDH[J]. China Biotechnology, 2010, 30(05): 36-42.
[11] . Generation of the Antibody against the schistosoma japonicum antigen Sj22 with genetic immunization[J]. China Biotechnology, 2007, 27(1): 6-10.